Augmentation of Cardiac Contractility Mediated by the Human &bgr;3-Adrenergic Receptor Overexpressed in the Hearts of Transgenic Mice
暂无分享,去创建一个
T. Kohout | R. Lefkowitz | H. Rockman | L. Mao | P. McDonald | S. Perry | H. Takaoka
[1] Marc G. Caron,et al. Control of Myocardial Contractile Function by the Level of β-Adrenergic Receptor Kinase 1 in Gene-targeted Mice* , 1998, The Journal of Biological Chemistry.
[2] Ellson Y. Chen,et al. Overview of manual and automated DNA sequencing by the dideoxy chain termination method , 1991 .
[3] F. Lönnqvist,et al. Tissue distribution of beta 3-adrenergic receptor mRNA in man. , 1993, The Journal of clinical investigation.
[4] R. Lefkowitz,et al. Enhanced myocardial function in transgenic mice overexpressing the beta 2-adrenergic receptor. , 1994, Science.
[5] S. Vatner,et al. Differences in beta 3-adrenergic receptor cardiovascular regulation in conscious primates, rats and dogs. , 1996, The Journal of pharmacology and experimental therapeutics.
[6] D. Hoyer,et al. (+/-)[125Iodo] cyanopindolol, a new ligand for beta-adrenoceptors: identification and quantitation of subclasses of beta-adrenoceptors in guinea pig. , 1981, Naunyn-Schmiedeberg's archives of pharmacology.
[7] T. Nakano,et al. The negative inotropic effect of beta3-adrenoceptor stimulation in the beating guinea pig heart. , 2000, Journal of cardiovascular pharmacology.
[8] R. Lefkowitz,et al. Enhanced Myocardial Function inTransgenic Mice Overexpressing theP2-Adrenergic Receptor , 1994 .
[9] K. Higashi,et al. Attenuation by glutathione of hsp72 gene expression induced by cadmium in cisplatin-resistant human ovarian cancer cells. , 1999, Biochemical pharmacology.
[10] R. A. Johnson,et al. Assay of adenylyl cyclase catalytic activity. , 1991, Methods in enzymology.
[11] J. Montastruc,et al. Peripheral cardiovascular actions of SR 58611 A, a beta 3‐adrenoceptor agonist, in the dog: lack of central effect , 1999, Fundamental & clinical pharmacology.
[12] S. Liggett,et al. Structural basis for receptor subtype-specific regulation revealed by a chimeric beta 3/beta 2-adrenergic receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[13] A. Strosberg. Structure and function of the beta 3-adrenergic receptor. , 1997, Annual review of pharmacology and toxicology.
[14] 北村 哲也. The Negative Inotropic Effect of β3-Adrenoceptor Stimulation in the Beating Guinea Pig Heart , 2000 .
[15] J. Hare,et al. beta(3)-adrenoceptor deficiency blocks nitric oxide-dependent inhibition of myocardial contractility. , 2000, The Journal of clinical investigation.
[16] D. Bernstein,et al. Cardiovascular and Metabolic Alterations in Mice Lacking Both β1- and β2-Adrenergic Receptors* , 1999, The Journal of Biological Chemistry.
[17] F. Charpentier,et al. Functional beta3-adrenoceptor in the human heart. , 1996, The Journal of clinical investigation.
[18] A. Strosberg. STRUCTURE AND FUNCTION OF THE 3 -ADRENERGIC RECEPTOR , 1997 .
[19] P. Gazzotti,et al. Purification and Reconstitution of the Ca2+-Pumping ATPase of Red Blood Cells , 1994 .
[20] A. Strosberg,et al. Molecular characterization of the human beta 3-adrenergic receptor. , 1989, Science.
[21] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .
[22] W. Lederer,et al. Cellular and functional defects in a mouse model of heart failure. , 2000, American journal of physiology. Heart and circulatory physiology.
[23] T. Wieland,et al. Measurement of receptor-stimulated guanosine 5'-O-(gamma-thio)triphosphate binding by G proteins. , 1994, Methods in enzymology.
[24] L. Luttrell,et al. The β3-Adrenergic Receptor Activates Mitogen-activated Protein Kinase in Adipocytes through a Gi-dependent Mechanism* , 1999, The Journal of Biological Chemistry.
[25] A. Strosberg,et al. Stimulation of the extracellular signal-regulated kinase 1/2 pathway by human beta-3 adrenergic receptor: new pharmacological profile and mechanism of activation. , 1999, Molecular pharmacology.
[26] R. Fremeau,et al. Distribution of β3-adrenoceptor mRNA in human tissues , 1995 .
[27] M. Bristow. Why does the myocardium fail? Insights from basic science , 1998, The Lancet.
[28] R. Miller,et al. A selective human beta3 adrenergic receptor agonist increases metabolic rate in rhesus monkeys. , 1998, The Journal of clinical investigation.
[29] C. Gauthier,et al. Beta 3‐adrenoceptor stimulation induces vasorelaxation mediated essentially by endothelium‐derived nitric oxide in rat thoracic aorta , 1999, British journal of pharmacology.
[30] B. Lowell,et al. Targeted Disruption of the β3-Adrenergic Receptor Gene * , 1995, The Journal of Biological Chemistry.